“…The journal remained very selective in accepting COVID-19 related submissions, publishing only two particularly significant articles comparing virulence among SARS-CoV-2 variants [ 82 ] and evaluating pandemic-associated cough [ 54 ]. Other notable publications in the area of infectious disease included a State-of-the-Art review of Strongyloides stercoralis [ 83 ], an outcome analysis of Blastomycosis infections [ 84 ], and an investigation of cytomegalovirus (CMV) infection in lung transplant recipients [ 85 ].…”